Title: Hyperinsulinemia in Polycystic Ovary Syndrome
Authors: Dr P. Lekshmi Ammal, Dr S.Krishnadas
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.14
Abstract
Background: Polycystic ovary syndrome is one of the most common endocrinopathies affecting 4.7% of women in reproductive age group contribute to a major share of anovulatory infertility. It is more prevalent in South Asian Women than in Caucasians though it can prevail in women of any ethnicity. PCOS is associated with 75% of anovulatory infertility. Even if they conceive, they can have very high pregnancy loss rates. The primary defect in PCOS may be insulin resistance leading to hyperinsulinemia and abnormal glucose tolerance which is present in 60 – 70 % of PCOS women. Understanding the role of insulin resistance in PCOS has led to the successful use of insulin sensitizing drugs in the treatment of this syndrome.
Objective: To study the prevalence of hyperinsulinemia and abnormal glucose tolerance among women with PCOS and to study the relationship between hyperinsulinemia and abnormal glucose tolerance, obesity, hyperandrogenism, acanthosis nigricans, infertility, gonadotropin profile and ovarian ultrasound morphology.
Materials and Methods: It was conducted as a prospective observational study. All patients diagonised of PCOS based on the ESHRE – ROTTERDAM revised consensus 2003 were included in the study. Patients with hyperandrogenemia due to other causes were excluded. A detailed history, examinations, ultrasound, oral glucose tolerance test, fasting insulin etc were done. Data analysis was performed using SPSS 16.
Results: The prevalence of hyperinsulinemia among PCOS patients was found to be 47.7%.in PCOS women hyperinsulinemia patients were found to have higher BMI, FI and lower FBS: FI compared to non – hyperinsulinemia women.
Conclusion: PCOS has an increased prevalence among obese women. Many women with PCOS are likely to have hyperinsulinemia, the earliest marker of insulin resistance and increased central fat distribution.
Keywords: Polycystic Ovary Syndrome, obesity, hyperinsulinemia.
References
1. 1. March W A, Moore VM, Willson KJ et al. The prevalence of PCOS in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544 – 51.
2. Pierpont T, McKiegue PM, Issacs AJ et al. Mortality in women with polycystic ovary syndrome at long term follow up. J Clin Epidermiol 1998; 51: 581 – 586.
3. Balen AH, Konway GS, Kaltsas G et al. Polycystic ovary syndrome. The spectrum of the disorder in 1741 patients. Hum Reprod 1995; 10: 2107 – 2111.
4. Asuncion M, Calvo RM, Sancho J et al. A prospective study of the prevalence of polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434 – 2438.
5. Goldzeiher JW. Polycystic ovarian disease. Fertil Steril 1981; 35: 371 – 394.
6. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: exper-ience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004; 89: 453 – 462.
7. Kyei A, Tab SL, Zaidi J, Jacobs HS. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Human Reprod 1998; 13: 1437 – 41.
8. Catherine M, DeUgarte, Alfred A. Bartikyccu, Ricardo Azziz. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility 2005; 83(5): 1454 – 1460
9. Ehrmann DA. Polycystic ovary syndrome. New Engl J Med 2005; 352: 1223 – 1236.
10. Legro RS, Kunselman AR, dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndr-ome. Am J Med 2001; 111: 607 – 613.
11. Sally KE, Wickham EP, et al. Glucose intolerance in PCOS –a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007; 92: 4546 – 4556.
12. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, et al. Glucose indices, health behaviors, and incidence of diabetes in Australia; the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008; 31: 267 – 272.
13. Chandalia M, Abate N, et al. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329 – 2335.